RECOMMENDATION IF PIPERACILLIN TAZOBACTAM WAS INITIATED AS EMPIRIC THERAPY FOR UNCOMPLICATED CYSTITIS CAUSED BY AN ORGANISM LATER IDENTIFIED AS AN ESBL E AND CLINICAL IMPROVEMENT OCCURS, NO CHANGE OR EXTENSION OF ANTIBIOTIC THERAPY IS NECESSARY <A RECOMMENDATION IF PIPERACILLIN TAZOBACTAM WAS INITIATED AS EMPIRIC THERAPY FOR UNCOMPLICATED CYSTITIS CAUSED BY AN ORGANISM LATER IDENTIFIED AS AN ESBL E AND CLINICAL IMPROVEMENT OCCURS, NO CHANGE OR EXTENSION OF ANTIBIOTIC THERAPY IS NECESSARY <A
68 veces visto
Ayúdanos a mantener la plataforma en funcionamiento y eliminar todos estos banners. 🥺
